Laura D’Erasmo

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh et al. · The Lancet · 2022 · 189 citations · Full text

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +7

Clinical and biochemical features of different molecular etiologies of familial chylomicronemia

Robert A. Hegele, Amanda J. Berberich, Matthew R. Ban et al. · Journal of clinical lipidology · 2018 · 157 citations · Full text

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy

Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti et al. · Scientific Reports · 2018 · 79 citations · Full text

Genetics, Genetic Epidemiology, Human Polymorphism +26

Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

Manuela Casula, Elena Olmastroni, Angela Pirillo et al. · Atherosclerosis · 2018 · 75 citations · Full text

Obesity, Metabolic Syndrome, Lipid Analysis +10

Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy

Laura D’Erasmo, Angelo B. Cefalù, Davide Noto et al. · Advances in Therapy · 2017 · 72 citations

Metabolic Syndrome, Real-world Clinical Experience, Lipid Disorder +11